Target intelligence / Profile preview

Tyrosine-protein kinase JAK3 (JAK3)

Target
JAK3
Molecular classification
Enzyme, Tyrosine Kinase, Protein Kinase, Non-receptor tyrosine kinase
01

Overview

Tyrosine-protein kinase JAK3 (Janus kinase 3, JAK-3) is a non-receptor tyrosine kinase primarily involved in signal transduction for cytokine receptors that share the common gamma chain (γc), such as those for interleukins IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. It plays a crucial role in hematopoiesis—especially T-cell development—and mediates essential signaling events in both innate and adaptive immunity. Mutations can lead to SCID or leukemia. Selective inhibitors targeting Cys909 are used therapeutically.

Other names
Janus kinase 3JAK-3Leukocyte janus kinaseL-JAK
02

Mechanism of action

JAK3 inhibition

03

Biological functions

Signal transductionImmune responseCell proliferationHematopoiesisCytokine receptor signaling
04

Disease associations

Severe Combined Immunodeficiency (SCID)LeukemiaCancerAutoimmune diseasesRheumatoid Arthritis
05

Safety considerations

ImmunosuppressionIncreased risk of infectionPotential for off-target effects

Beyond the preview

Go deeper on Tyrosine-protein kinase JAK3 (JAK3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tyrosine-protein kinase JAK3 (JAK3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call